Abstract
Coronary artery disease remains the most common cause of mortality and morbidity in the diabetic population due to accelerated atherosclerosis driven by complex pathophysiological effect of hyperglycemia, augmented serum levels of advanced glycation end-products, insulin resistance, and high free fatty acid levels. Advancements in percutaneous coronary intervention (PCI) and advent of newer generation drug eluting stents (DESs) have improved outcomes in patients with diabetes mellitus. However, diabetes is still a strong risk factor for adverse clinical outcomes after PCI due to higher rate of restenosis, stent thrombosis, and lower 1-year survival in diabetic compared to non-diabetic population. Bioresorbable scaffolds (BRSs) are novel devices for coronary revascularization and offer potential to improve long-term outcomes. It remains to be proven whether PCI with BRS may improve the outcomes in diabetic patients. This chapter reviews the revascularization strategy in patients with diabetes mellitus, with particular focus on the role of BRS in this patient group.
| Original language | English |
|---|---|
| Title of host publication | Bioresorbable Scaffolds |
| Subtitle of host publication | From Basic Concept to Clinical Applications |
| Publisher | CRC Press |
| Pages | 379-388 |
| Number of pages | 10 |
| ISBN (Electronic) | 9781498779777 |
| ISBN (Print) | 9781498779746 |
| DOIs | |
| Publication status | Published - 01-01-2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
- General Biochemistry,Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'Bioresorbable scaffolds for treating coronary artery disease in patients with diabetes mellitus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver